# Liposomal Bupivacaine vs Peripheral Nerve Block

> **NCT03922620** · PHASE4 · TERMINATED · sponsor: **Geisinger Clinic** · enrollment: 1 (actual)

## Conditions studied

- Pain, Acute
- Surgery
- Anesthesia
- Opioid Use

## Interventions

- **DRUG:** Liposomal bupivacaine
- **DRUG:** Peripheral Nerve Block

## Key facts

- **NCT ID:** NCT03922620
- **Lead sponsor:** Geisinger Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-01-23
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Additional published information on the topic since starting the study
- **Last updated:** 2023-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03922620

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03922620, "Liposomal Bupivacaine vs Peripheral Nerve Block". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03922620. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*